4//SEC Filing
GARRITY THOMAS J 4
Accession 0001209191-21-020289
CIK 0001016169other
Filed
Mar 11, 7:00 PM ET
Accepted
Mar 12, 7:04 PM ET
Size
8.8 KB
Accession
0001209191-21-020289
Insider Transaction Report
Form 4
GARRITY THOMAS J
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-03-11−50,000→ 0 totalExercise: $1.12Exp: 2026-06-02→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2021-03-11$1.12/sh+50,000$56,000→ 274,406 total - Sale
Common Stock
2021-03-11$4.28/sh−50,000$214,000→ 224,406 total
Footnotes (2)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The options vested and became exercisable in four equal quarterly installments from the grant date of June 2, 2016.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001275012
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 7:00 PM ET
- Accepted
- Mar 12, 7:04 PM ET
- Size
- 8.8 KB